Filter by: patients
Home > Community Treatment Reports and Side Effects > Nitrazepam Treatment Report
What is Nitrazepam?

Nitrazepam is a benzodiazepine used in the short-term management of insomnia and for the treatment of myoclonic seizures.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Insomnia 5 2 Efficacy_moderate Efficacy_slight
Anxious mood 3 1 Efficacy_moderate
Sleep problems 3 0
Other 1 0

See all 7 patients currently taking Nitrazepam

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Nitrazepam

Dizziness 1

Reported Dosages

  10mg as needed 5 mg daily 20 mg daily 420 mg daily
  1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Nitrazepam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2   Other: 50%
Did not seem to work 1   Did not seem to work: 25%
Personal research 1   Personal research: 25%
Doctor's advice 1   Doctor's advice: 25%

See all 4 patients who’ve stopped taking Nitrazepam

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Nitrazepam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Nitrazepam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Nitrazepam

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Nitrazepam

Very
 0 0%
Somewhat
 0 0%
A little
 1 50%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Nitrazepam

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 1 100%
< $25
 0 0%

Report created on February 11, 2012.